Loading
Life sciences · Journal article
Traditional & Kampo Medicine · September 30, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT Aim Peripheral neuropathic pain (PNP) is a frequent, distressing adverse effect of taxanes. Paclitaxel (PTX)‐induced PNP is well described, but docetaxel (DTX)‐induced PNP has received little attention. Sokeikakketsuto (SOKT) is a Kampo formula for cold‐aggravated musculoskeletal and neuralgic pain with blood stasis; we report its effect on taxane‐induced PNP. Methods Five women with breast cancer and taxane‐induced PNP (predominantly DTX) received SOKT. Effect was graded from the numerical rating scale (NRS). Concordance of each patient's Kampo pattern ( sho ) with the classical sho of SOKT was assessed. Results SOKT was effective in four cases and slightly effective in one; no case worsened. The magnitude of NRS improvement paralleled sho concordance. No adverse effects occurred. Conclusion SOKT relieved taxane‐induced, predominantly DTX‐induced, PNP, with benefit tracking sho concordance. Sho ‐based selection and the qualitative character of the pain may guide Kampo therapy for taxane‐induced PNP.